It is essential for researchers to keep abreast of the work being done by colleagues in a variety of disciplines. To facilitate this, the UCLA-CDU CFAR and the UCLA AIDS Institute sponsors a bi-weekly conference featuring presentations made by researchers working in both basic and translational sciences, clinical therapeutics and biomedical prevention. The topics covered include, among many others, host-virus interactions, novel therapeutics, vaccines, stem-cell research, aging, and viral pathogenesis. The Weekly Multidisciplinary Virology Seminar Series is an in-person meeting from 9:00am to 10:00am in the Biomedical Science Research Building (BSRB) 154. Masks are HIGHLY recommended and we would like to request no eating or drinking during the meeting. Thank you for your cooperation.
For more information regarding the Weekly Multidisciplinary Virology Seminar Series and/or to be added to the listserv for these meetings, please contact Rina Lee-Cha.
November 29, 2022 | |||
9:00am | Sandro Satta (Kelesidis Lab) | “SARS-CoV-2: A glance beyond the surface” | |
9:30am | N/A | N/A | |
December 13, 2022 | |||
9:00am | Yvonne Bryson | “HIV remission and possible cure in a woman of mixed race following a haplo/cord CCR5 delta 32/32 transplant” | |
9:30am | Swati Dubey (Arumugaswami Lab) | “Differential Pathogenesis of Hantaviruses” | |
January 10, 2023 | |||
9:00am | Kari-Ann Takano (Morizono Lab) | “Development of a B-cell Targeting Lentiviral Vector” | |
9:30am | Jennifer Fulcher | “Examining the Role of the Microbiome in HIV Susceptibility” |
|
January 24, 2023 | |||
9:00am | Paul Ayoub (Kohn Lab) | “Lentiviral Vectors for Regulated Expression to Treat X-Linked Lymphoproliferative Disease” | |
9:30am | Zheng Cao (Wen Lab) | “A multifunctional booster for anti-cancer T cell immunity” | |
February 7, 2023 | |||
9:00am | Karly Nisson (Fregoso Lab) | “Investigating the interactions between the lentiviral accessory protein Vpr and its host target, CCDC137” | |
9:30am | Laura Martinez (Epeldegui Lab) | “Extracellular vesicles bearing PD-L1, CD40, TNF-RII or IL-6R⍺ are significantly associated with AIDS-NHL risk” | |
February 21, 2023 (*in-person) | |||
9:00am | Celine Snedden (Lloyd-Smith Lab) | “PCR data accurately predict infectious virus: a characterization of SARS-CoV-2 in non-human primates” | |
March 7, 2023 | |||
9:00am | Arjit Jeyachandran (Arumugaswami Lab) | “Systems Biology Approaches to Define Hantaviral Pathogenesis Mechanism” | |
9:30am | Ayub Ali (Yang Lab) | “Targeting HCMV by a Novel Bispecific Antibody with Therapeutic Potential” | |
March 21, 2023 | |||
9:00am | Vivian Yang (Fregoso Lab) | “Identification and Characterization of a Novel HIV Latency Reversing Agent” | |
9:30am | Serina Huang (Li Lab) | “Positive selection analyses reveal residues important for the replication inhibition activity of ZAP” | |
April 4, 2023 | |||
9:00am | Mehdi Bouhaddou | “SARS-CoV-2 variants evolve convergent strategies to remodel the host response” | |
9:30am | Pu-Lin Teng (Wu Lab) | “KSHV dUTPase ORF54 hijacks ESCRT-I to downregulate IFNAR1” | |
April 18, 2023 | |||
9:00am | Alexander Stevens (Zhou Lab) | TBD | |
9:30am | William Mu (Kitchen Lab) | TBD | |
May 2, 2023 | |||
9:00am | Mayra Carrillo (Kitchen Lab) | TBD | |
9:30am | Shilin Chen (Wen Lab) | TBD |